What is preventing the use of high path avian flu vaccines?

High path avian influenza has affected close to 170 million birds over the past three years.

USDA is working to combat the virus and lower egg prices through a new strategy, which includes funding for vaccine research.

American Farm Bureau Economist Bernt Nelson spoke with RFD-TV’s Suzanne Alexander about current HPAI vaccines and what is preventing the use of them.

Related Stories
U.S. Agriculture Secretary Tom Vilsack announced the USDA will help dairy producers dealing with High-Path Avian Flu (HPAI) H5N1 outbreaks in their herds.
Starting Monday, April 29, the USDA will require free avian flu (HPAI H5N1) testing on all dairy cattle before interstate travel. Positive cases must be directly reported to the USDA for tracing.
After months of declining consumer egg prices, buyers could be facing a sharp increase in costs as prices surge upwards once again.
Researchers out of the United Kingdom are using gene editing technology to help make High-Path Avian Flu less of a threat to poultry.
To mark the end of National Chicken Month, we take a look at how the U.S. poultry industry is making a slow and steady recovery following the widespread outbreak of High-Path Avian Flu (HPAI) in 2022 that devastated commercial flocks across the country.